Discovery and reporting of clinically-relevant germline variants in advanced cancer patients assessed using whole-exome sequencing
Tuo Zhang(Cornell University), Olivier Elemento(Cornell University), Ivan Iossifov(Cold Spring Harbor Laboratory), Mark A. Rubin(University of Bern), Jenny Xiang(Cornell University), Steven M. Lipkin(National Institutes of Health), Alessandro Romanel(University of Trento), Juan Miguel Mosquera(NewYork–Presbyterian Hospital), Andrea Sboner(Cornell University), Himisha Beltran(Dana-Farber Cancer Institute), Colin C. Pritchard(Animal and Plant Health Agency), Adrian Y. Tan(NewYork–Presbyterian Hospital), Peter S. Nelson(Fred Hutch Cancer Center), Francesca Demichelis(University of Trento), Xiaojun Feng(Cornell University), Hanna Rennert(Cornell University), Joanna Cyrta(Institut Curie), Yaohua Xue(Southern Medical University), Kenneth Eng(Cornell University)
Cited by 2
Related Papers
Tumour exosome integrins determine organotropic metastasis
|Nature|2015|5.2k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver
|Nature Cell Biology|2015|2.7k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k